Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-31 @ 5:59 AM
Study NCT ID:
NCT03567304
Status:
UNKNOWN
Last Update Posted:
2019-07-24
First Post:
2018-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine
Sponsor:
Chiang Mai University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MED-2561-05276
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None